Viking Therapeutics (VKTX) Tops Q2 EPS by 6c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), $0.06 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi
• Varonis Said To Weigh Sale After Takeover Interest - Bloomberg